BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Foresees the Future Trend of Laboratory Technology

NIKYANG made a stunning appearance at the 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021) with its latest innovative labo...

September 28, 2021 | News

Transcenta Received IND Clearance from NMPA of its Anti-sclerostin Monoclonal Antibody TST002

Currently there are over 100 million of people with various degree of osteoporosis and 4 million people in China with severe osteoporos...

September 27, 2021 | News

Johnson & Johnson Innovation Announces Awardees of the Digital Technologies of Tomorrow QuickFire Challenge

Johnson & Johnson Innovation LLC together with Johnson & Johnson Medical Shanghai Ltd. today at AmCham China's Technology and Innovation Summit nam...

September 24, 2021 | News

Everest to support future development and commercialization globally for the treatment of renal diseases

Collaboration consolidates Everest's leadership in the renal space Everest Medicines will pay Sinovent and SinoMab USD $12 million in upfront and up to $5...

September 17, 2021 | News

Sartorius to open new Application and Service Hub in Shanghai

▪ Supporting Chinese customers with cutting-edge innovations to accelerate technological breakthroughs in life science research and biopharma proce...

September 16, 2021 | News

Allianz Partners expands its Digital Health Assistant to ten markets in Asia-Pacific

Initially launched in Europe, this new service gives customers access to a range of digital health services and medical professionals This digital ...

September 16, 2021 | News

Clover Biopharmaceuticals to Produce COVID-19 Vaccine

Clover Biopharmaceuticals, Ltd. (Clover), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, toda...

September 14, 2021 | News

Jemincare declared Ph I trial of its anti-SARS-CoV-2 neutralizing antibody

The clinical trial of JMB2002 was stated in January 2021. A single-center, randomized, double-blind, placebo-controlled, single-dose escalation phas...

September 14, 2021 | News

China strengthen it's Proton Therapy System

Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research...

September 13, 2021 | News

Happiness Biotech Announced The Launch of Its Lucidum Tablets

"To prevent false advertisement in the healthcare industry and prohibit defective health products from entering the market, China has set forth s...

September 13, 2021 | News

Cytiva triples single-use consumables capacity in China

Three new manufacturing lines were successfully launched in under ten months, with an additional eight new lines planned to launch in Q3 2022.&nbs...

September 10, 2021 | News

Yiling Pharmaceutical's Yishen Yangxin Anshen Tablets Granted Drug Certificate

With the functions of reinforcing kidney, nourishing heart, and tranquilizing mind, this drug offers a new treatment for insomnia with the symptoms of slee...

September 08, 2021 | News

GeneQuantum ,BrighGene to develop antibody immune agonist conjugates

GQ1007 is a new type of antibody-drug conjugate. It is an antibody conjugated to a potent immune agonist. In recent years, immunotherapeutic antibody drugs...

September 07, 2021 | News

China to provide a best-in-class CAR-T therapy

The first CAR-T product independently developed in China and approved as a Category 1 biologics product, and the sixth approved CAR-T product g...

September 07, 2021 | News

Stay Connected